Clinical Trial Update: Study to Re-assess and Re-confirm Data Previously Recorded About the Incidence and Severity of Acute Abdominal "Pancreatitis" Episodes in Lipoprotein Lipase Deficient (LPLD) Subjects Previously Enrolled on AMT Clinical Studies

View source ↗

Summary

A clinical trial update from Amsterdam Molecular Therapeutics to re-assess and re-confirm data on the incidence and severity of acute pancreatitis in Lipoprotei…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lipoprotein Lipase Deficiency

Drugs mentioned

• Glybera (alipogene tiparvovec)

Snippet

Sponsor: Amsterdam Molecular Therapeutics | Conditions: Lipoprotein Lipase Deficiency | Status: UNKNOWN